Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:391790.
doi: 10.1155/2015/391790. Epub 2015 Mar 4.

Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis

Grazia Maria Virzì  1 , Anna Clementi  2 , Massimo de Cal  1 , Alessandra Brocca  3 , Sonya Day  1 , Silvia Pastori  4 , Chiara Bolin  5 , Giorgio Vescovo  6 , Claudio Ronco  1
Affiliations

Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis

Grazia Maria Virzì et al. Oxid Med Cell Longev. 2015.

Abstract

Cardiorenal Syndrome Type 1 (Type 1) is a specific condition which is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Even though its pathophysiology is complex and not still completely understood, oxidative stress seems to play a pivotal role. In this study, we examined the putative role of oxidative stress in the pathogenesis of CRS Type 1. Twenty-three patients with acute heart failure (AHF) were included in the study. Subsequently, 11 patients who developed AKI due to AHF were classified as CRS Type 1. Quantitative determinations for IL-6, myeloperoxidase (MPO), nitric oxide (NO), copper/zinc superoxide dismutase (Cu/ZnSOD), and endogenous peroxidase activity (EPA) were performed. CRS Type 1 patients displayed significant augmentation in circulating ROS and RNS, as well as expression of IL-6. Quantitative analysis of all oxidative stress markers showed significantly lower oxidative stress levels in controls and AHF compared to CRS Type 1 patients (P < 0.05). This pilot study demonstrates the significantly heightened presence of dual oxidative stress pathway induction in CRS Type 1 compared to AHF patients. Our findings indicate that oxidative stress is a potential therapeutic target, as it promotes inflammation by ROS/RNS-linked pathogenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
See this image and copyright information in PMC

References

    1. Clementi A., Virzi G. M., Goh C. Y., et al. Cardiorenal syndrome type 4: a review. Cardiorenal Medicine. 2013;3(1):63–70. doi: 10.1159/000350397. - DOI - PMC - PubMed
    1. Ronco C., Chionh C.-Y., Haapio M., Anavekar N. S., House A., Bellomo R. The cardiorenal syndrome. Blood Purification. 2009;27(1):114–126. doi: 10.1159/000167018. - DOI - PubMed
    1. Ronco C., Cicoira M., McCullough P. A. Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. Journal of the American College of Cardiology. 2012;60(12):1031–1042. doi: 10.1016/j.jacc.2012.01.077. - DOI - PubMed
    1. Ronco C., Haapio M., House A. A., Anavekar N., Bellomo R. Cardiorenal syndrome. Journal of the American College of Cardiology. 2008;52(19):1527–1539. doi: 10.1016/j.jacc.2008.07.051. - DOI - PubMed
    1. Virzì G. M., Day S., de Cal M., Vescovo G., Ronco C. Heart-kidney crosstalk and role of humoral signaling in critical illness. Critical Care. 2014;18(1, article 201) doi: 10.1186/cc13177. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources